Advertisement
Research ArticleInflammation, Immunopharmacology, and Asthma

Topical Application of ASN008, a Permanently-charged Sodium Channel Blocker, Shows Robust Efficacy, a Rapid Onset and Long Duration of Action in a Mouse Model of Pruritus

Roshni Ramachandran, Scott K. Thompson, Shelle Malkmus, Sandeep Gupta, Tsutomu Mieda, Jun-Hsiang Lin and Tony L Yaksh
Journal of Pharmacology and Experimental Therapeutics July 2, 2020, jpet.120.265074; DOI: https://doi.org/10.1124/jpet.120.265074
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleInflammation, Immunopharmacology, and Asthma

Topical Application of ASN008, a Permanently-charged Sodium Channel Blocker, Shows Robust Efficacy, a Rapid Onset and Long Duration of Action in a Mouse Model of Pruritus

Roshni Ramachandran, Scott K. Thompson, Shelle Malkmus, Sandeep Gupta, Tsutomu Mieda, Jun-Hsiang Lin and Tony L Yaksh
Journal of Pharmacology and Experimental Therapeutics July 2, 2020, jpet.120.265074; DOI: https://doi.org/10.1124/jpet.120.265074
Reddit logo Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement